Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Long-term PM2.5 exposure may lead to more severe COVID-19
Long-term exposure to particulate matter ≤2.5 μm (PM2.5) results in increased admission to hospital for COVID-19, according to a recent study.
Long-term PM2.5 exposure may lead to more severe COVID-19
26 Nov 2021Convalescent plasma ineffective for COVID-19
A recent Singapore meta-analysis of randomized controlled trials (RCT) has found no clear clinical benefit to using convalescent plasma (CP) for patients with the coronavirus disease 2019 (COVID-19), especially in those with severe disease.
Convalescent plasma ineffective for COVID-19
26 Nov 2021Single tocilizumab dose effectively suppresses systemic inflammation in COVID-19
A single injection of tocilizumab is enough to weaken systemic inflammation for up to 7 days in patients with the coronavirus disease 2019 (COVID-19), a recent study suggests.
Single tocilizumab dose effectively suppresses systemic inflammation in COVID-19
25 Nov 2021Suboptimal influenza vaccination persists among insurance holders despite no copayment
The coverage of influenza vaccination for Medicare beneficiaries remains poor, reports a study, noting missed opportunities despite availability of vaccines with no copayment. In addition, there are still disparities in vaccination uptake by race/ethnicity.
Suboptimal influenza vaccination persists among insurance holders despite no copayment
24 Nov 2021Automated text messaging service helps reduce deaths in outpatients with COVID-19
Adults newly diagnosed with COVID-19 in outpatient settings and enrolled in an automated remote monitoring service are less likely to succumb to the disease potentially due to more frequent telemedicine encounters and earlier presentation to the emergency department (ED), a study has shown.
Automated text messaging service helps reduce deaths in outpatients with COVID-19
24 Nov 2021Hypertension tied to cardiac injury in COVID-19 patients
In patients with the coronavirus disease 2019 (COVID-19), hypertension aggravates the risk of cardiac injury and severe disease phenotype, a recent study has found.
Hypertension tied to cardiac injury in COVID-19 patients
24 Nov 2021Sotrovimab may reduce COVID-19 disease progression
The pan-sarbecovirus monoclonal antibody sotrovimab appears to reduce the risk of COVID-19 disease progression in high-risk patients, according to interim results of the phase III COMET-ICE* trial.
Sotrovimab may reduce COVID-19 disease progression
23 Nov 2021High acute-to-chronic glycaemic ratio tied to worse prognosis in T2D patients with COVID-19
Type 2 diabetes (T2D) patients with COVID-19 who have elevated acute-to-chronic (A/C) glycaemic ratio are at increased risk of adverse outcomes, including in-hospital mortality, intensive care unit (ICU) admission, and mechanical ventilation, a study has found.